Atlas Trials

Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

Clinical trial NCT00354367 · WITHDRAWN

Trial details

NCT number
NCT00354367
Sponsor
UCB Pharma
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Crohn Disease
Start date
2007-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.